Bortezomib resistance in THP-1 cell line
Source: NCBI BioProject (ID PRJNA105955)
Source: NCBI BioProject (ID PRJNA105955)
0 0
Project name: Homo sapiens
Description: Bortezomib is a proteasome inhibitor used in severel different hematological malignancies. Resistance to this drug is still poorly understood. In order get more insight in the resistance mechanism, we developed several bortezomib resistant subclones of the THP-1 monocytic/macrophage cell line. On these subclones expression arrays were performed.Overall design: We performed expression array three different bortezomib resistant subclones of the THP-1 cell line. The resistant subclones were spotted against the parental THP-1 wildtype cell line.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Microarray Core Facility, Pathology, Vrije Universiteit Medical Center
Literatures
- PMID: 18565852
Release date: 2008-06-14
Last updated: 2008-06-12